1. Home
  2. TECH vs TXRH Comparison

TECH vs TXRH Comparison

Compare TECH & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • TXRH
  • Stock Information
  • Founded
  • TECH 1976
  • TXRH 1993
  • Country
  • TECH United States
  • TXRH United States
  • Employees
  • TECH N/A
  • TXRH N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • TXRH Restaurants
  • Sector
  • TECH Health Care
  • TXRH Consumer Discretionary
  • Exchange
  • TECH Nasdaq
  • TXRH Nasdaq
  • Market Cap
  • TECH 9.9B
  • TXRH 10.9B
  • IPO Year
  • TECH 1989
  • TXRH 2004
  • Fundamental
  • Price
  • TECH $63.94
  • TXRH $172.56
  • Analyst Decision
  • TECH Buy
  • TXRH Buy
  • Analyst Count
  • TECH 13
  • TXRH 17
  • Target Price
  • TECH $70.58
  • TXRH $193.65
  • AVG Volume (30 Days)
  • TECH 2.3M
  • TXRH 995.7K
  • Earning Date
  • TECH 11-05-2025
  • TXRH 11-06-2025
  • Dividend Yield
  • TECH 0.50%
  • TXRH 1.58%
  • EPS Growth
  • TECH N/A
  • TXRH 19.03
  • EPS
  • TECH 0.46
  • TXRH 6.56
  • Revenue
  • TECH $1,219,635,000.00
  • TXRH $5,670,615,000.00
  • Revenue This Year
  • TECH $3.72
  • TXRH $11.76
  • Revenue Next Year
  • TECH $7.67
  • TXRH $10.02
  • P/E Ratio
  • TECH $139.00
  • TXRH $26.31
  • Revenue Growth
  • TECH 5.23
  • TXRH 14.59
  • 52 Week Low
  • TECH $46.01
  • TXRH $148.73
  • 52 Week High
  • TECH $80.80
  • TXRH $206.04
  • Technical
  • Relative Strength Index (RSI)
  • TECH 62.22
  • TXRH 51.67
  • Support Level
  • TECH $58.15
  • TXRH $173.77
  • Resistance Level
  • TECH $66.96
  • TXRH $180.39
  • Average True Range (ATR)
  • TECH 1.86
  • TXRH 3.87
  • MACD
  • TECH 0.20
  • TXRH 0.35
  • Stochastic Oscillator
  • TECH 66.85
  • TXRH 52.42

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About TXRH Texas Roadhouse Inc.

Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

Share on Social Networks: